| 2025 | EverZom enters Research Collaboration with GENFiT including Exclusive License Option for EViV |  |
| 2025 | EverZom raises €10M to develop exosome-based biotherapies for inflammatory diseases |  |
| 2024 | Exclusive license agreement secured with Ergeano for EverGel |  |
| 2019 | Everzom signe une licence avec la start-up EverZom qui crée une plateforme de production d’outils biologiques |  |